Clinical trials: Pharmacist
Early Rheumatoid Arthritis
A Randomized Clinical Trial Evaluating the Efficacy of Clinical Pharmacist Assistance Along With Pharmaceutical and Non-pharmaceutical Therapy in the Early Rheumatoid Arthritis
Background: Rheumatoid arthritis (RA) is a progressive chronic autoimmune disease with a rising global burden, in which early diagnosis and timely therapeutic intervention are critical to preventing irreversible joint damage and…
- Trial name
- NCT07726355
- Testing
- Clinical Pharmacist Led Intervention, DMARD Therapy
- Where
- Egypt
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Deraya University
Medication Dosing Error
Working With Doctors and Pharmacists to Help Parents Give Children's Liquid Medicines Safely
The study objective is to assess the impact of an automated electronic health record (EHR)-based intervention that leverages e-prescriptions to support pharmacist adherence to recommended dispensing practices, with the goal of…
- Trial name
- NCT05146388
- Testing
- EHR-Based Approach
- Where
- 3 sites in United States
- Volunteers
- 500 people
- Sponsor
- NYU Langone Health
Major Neurocognitive Disorder
GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders
The model of care tested in the GPS project aims to optimize pharmacotherapy for seniors undergoing cognitive assessment or suffering from major neurocognitive disorder (MCND) at home.
- Trial name
- NCT04889794
- Testing
- GPS clinical intervention
- Where
- 2 sites in Canada
- Volunteers
- 400 people
- Sponsor
- CHU de Quebec-Universite Laval
Renal Impairments, Chronic Kidney Disease
Evaluation of Clinical Pharmacy Services and Drug Use in Renal Impairment.
Clinical pharmacy services aim to optimise medication use, enhance patient outcomes, and reduce the risk of drug-related harm through patient-centred pharmaceutical care.
- Conditions
- Renal Impairments, Chronic Kidney Disease, Acute Kidney Disease, Medication Errors
- Trial name
- RECAP-Rx (NCT07241494)
- Testing
- Clinical Pharmacist-Led Pharmaceutical Care Service and Renal Dose Adjustment, Education for renal adjusments
- Where
- Turkey (Türkiye)
- Volunteers
- 160 people
- Sponsor
- Istanbul University - Cerrahpasa
Tobacco Cessation, Health Warning Label
Health Warnings and Counseling for Smoking Cessation
Tobacco use remains persistently high across South Asia, despite numerous public health efforts, and continues to significantly contribute to the burden of non-communicable diseases (NCDs) such as cardiovascular disease…
- Conditions
- Tobacco Cessation, Health Warning Label, Hypertension, Non Communicable Chronic Diseases
- Trial name
- NCT07098065
- Testing
- Graphical health warnings, Graphical health warnings plus pharmacist-led counselling, Routine pharmacy services (no intervention)
- Where
- Bangladesh
- Volunteers
- 3,400 people
- Sponsor
- Hitotsubashi University
Pneumonia, COPD Asthma
Development and Evaluation of Clinical Pharmacy Services in Respiratory Diseases
Clinical pharmacists in the healthcare system are experts in therapeutics and the use of drugs. They routinely provide medication reviews and recommendations to patients and healthcare professionals.
- Conditions
- Pneumonia, COPD Asthma, COPD Exacerbation
- Trial name
- NCT05564156
- Testing
- Intervention groups
- Where
- Turkey (Türkiye)
- Volunteers
- 168 people
- Sponsor
- Bezmialem Vakif University
Heart Failure
Veterans Affairs Pharmacist Heart Failure Medication Titration Project 1
This is a randomized quality improvement project to evaluate the impact of an audit and feedback intervention to motivate pharmacists to provide heart failure (HF) medication management to patients in the Veterans Health…
- Trial name
- NCT06099808
- Testing
- Audit and Feedback Emails, Patient Specific Targets, Educational Resources
- Where
- United States
- Volunteers
- 110 people
- Sponsor
- Stanford University
Elderly, Chronic Disease
Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate Medication
The investigators propose that clinical pharmacist interventions would reduce the rate of adverse drug events in elderly patients taking potentially inappropriate medication.
- Trial name
- NCT00844025
- Testing
- Pharmacist intervention
- Where
- Taiwan
- Volunteers
- 120 people
- Sponsor
- Shin Kong Wu Ho-Su Memorial Hospital
Communication Research
Optimizing Medication Management by Older Adults Through the Med Wise Rx Community-based Program
This study's overall goal is to enhance older adults' communication skills to access medication information and services to manage their medications safely and effectively.
- Trial name
- NCT05751980
- Testing
- Med Wise Rx
- Where
- 4 sites in United States
- Volunteers
- 121 people
- Sponsor
- University of Wisconsin, Madison
AOD Prescription
Impact of Renal Function Availability to Community Pharmacist for Dispensing Direct Oral Anticoagulant in Ambulatory Patients on Bleeding Occurrence
The use of direct oral anticoagulants (AODs) in the prevention and treatment of thromboembolic diseases is increasing, with a favorable benefit/risk balance and improved quality of life for patients.
- Trial name
- Hemorrag-IR (NCT06739603)
- Testing
- pharmaceutical analysis
- Volunteers
- 1,920 people
- Sponsor
- Université de Reims Champagne-Ardenne
Diabetes Mellitus, Type 2
Effect of Pharmacists Treating Diabetes in a FQHC
This study is a randomized controlled cross-over trial, in the form of a proof of concept study that is designed to evaluate the health outcomes resulting from incorporating a licensed clinical pharmacist in a health care team to…
- Trial name
- NCT03134170
- Testing
- Pharmacist review of therapy
- Where
- United States
- Volunteers
- 239 people
- Sponsor
- Rutgers, The State University of New Jersey
Multiple Myeloma
A Survey on NINLARO Risk Management Plan (RMP) Material Utilization Among Pharmacists in Japan
This is a survey among pharmacists who have instructed NINLARO therapy in ixazomib, lenalidomide and dexamethasone (IRD) dosing to patients with relapsed/refractory multiple myeloma (rrMM).
- Trial name
- NCT05882279
- Testing
- No Intervention
- Where
- Japan
- Volunteers
- 330 people
- Sponsor
- Takeda
Hypertension
Alberta Clinical Trial in Optimizing Hypertension
The purpose of this study is to evaluate the effect of enhanced pharmacist care (patient identification, assessment, education, prescribing/titration of antihypertensive medications and close follow-up) on systolic blood pressure…
- Trial name
- RxAction (NCT00878566)
- Testing
- Enhanced pharmacist care, Usual Care
- Where
- Canada
- Volunteers
- 248 people, healthy volunteers welcome
- Sponsor
- University of Alberta
Drug-Related Side Effects and Adverse Reactions
Effect of a trAnSitional Pharmacist Intervention in geRiatric Inpatients on Hospitals Visits After dischargE
A randomized controlled trial will be performed in geriatric inpatients to investigate the impact of a multifaceted clinical pharmacy intervention on health related outcomes.
- Trial name
- ASPIRE (NCT04617340)
- Testing
- Multifaceted clinical pharmacy intervention
- Where
- Belgium
- Volunteers
- 827 people
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
All Hospitalzied Patients, No Specific Conditions Requires
A Comparative Study of ID Fellow-based VS. Pharmacist-based Antibiotic Pre-authorization
We will conduct a cluster randomized controlled trial to compare two antibiotic pre-authorization strategies (Fellow-based vs. Pharmacist-based).
- Trial name
- DUE (NCT01797133)
- Testing
- ID fellow-based antibiotic pre-authorization, Pharmacist-based antibiotic pre-authorization
- Where
- Thailand
- Volunteers
- 984 people
- Sponsor
- Siriraj Hospital
Hemodialysis, End Stage Renal Disease Requiring Hemodialysis
Pharmacist-led Intervention on Hemodialysis Patients' Therapy Adherence
A parallel-group, cluster-randomized, controlled trial designed to evaluate if hemodialysis patients benefit from BCT. The study includes two groups: usual care and pharmacist-led intervention groups.
- Trial name
- NCT06744738
- Testing
- Pharmacist led behavioral change technique
- Where
- Iraq
- Volunteers
- 72 people
- Sponsor
- Thuraya Safaa Ibrahim
Atherosclerotic Cardiovascular Disease
A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients
Patients who had an ASCVD event at an Intermountain hospital will be screened for eligibility to be randomized. Subjects who meet eligibility criteria will be randomized 1:1 to receive targeted care of their LDL-C through a…
- Trial name
- INCLUDE (NCT06571162)
- Testing
- Clinical Pharmacy Team, Usual Care
- Where
- United States
- Volunteers
- 400 people
- Sponsor
- Intermountain Health Care, Inc.
Hypertension
Pilot for a Community Pharmacy Service Model: Impact of a Pharmacist Monitored Patient Blood Pressure Readings
This study is designed to explore whether routine measurement of blood pressure by community pharmacists can improve patient adherence to blood pressure medications.
- Trial name
- NCT03323840
- Testing
- Incentivized Care
- Where
- United States
- Volunteers
- 33 people
- Sponsor
- Virginia Commonwealth University
Palliative Medicine
The Role of the Pharmacist and Pharmacogenomics in the Care of Seriously Ill Patients
Researchers are trying to learn more about how pharmacists and pharmacogenomic testing can help care providers improve control of symptoms and quality of life in seriously ill patients.
- Trial name
- NCT04251520
- Testing
- Pharmacogenomics testing, Pharmacist review
- Where
- United States
- Volunteers
- 2 people
- Sponsor
- Mayo Clinic
Hypertension
Mobilizing Community Hypertension Access Pilot
The Live Healthy Chicago (LHC) Community Pilot is a prospective, community-based study evaluating the feasibility, effectiveness, and economic impact of a pharmacist-led hypertension management program delivered in trusted…
- Trial name
- NCT07547345
- Testing
- Community-Based Multidisciplinary Hypertension Management Program
- Where
- United States
- Volunteers
- 200 people
- Sponsor
- Rush University Medical Center